Newborn screening for tyrosinemia type I: Further evidence that succinylacetone determination on blood spot is essential

Giancarlo La Marca, Sabrina Malvagia, Elisabetta Pasquini, Catia Cavicchi, Amelia Morrone, Federica Ciani, Silvia Funghini, Fabio Villanelli, Enrico Zammarchi, Renzo Guerrini

Research output: Contribution to journalArticle

Abstract

Tyrosinemia type I is a genetic disorder characterized by accumulation in the blood and urine of the toxicmetabolite succinylacetone (SUAC), not detectable in healthy samples. In many countries, newborns are screened for tyrosinemia type I using tyrosine as a primary marker. Unfortunately, tyrosine accumulation may take longer to occur and it may be not obvious when specimens are collected, in the first few days of life, as for new born screening. In 2008, we reported changes to simultaneously measure acylcarnitines, amino acids, and SUAC duringexpanded newborn screening. We established the usefulness of this method after identifying a first asymptomatic new born affected by tyrosinemia type I. Now we report a second infant with positive SUAC screening result (14.1 mmol/L, n.v.

Original languageEnglish
Pages (from-to)107-109
Number of pages3
JournalJournal of Inherited Metabolic Disease
Volume1
DOIs
Publication statusPublished - Nov 1 2011

Fingerprint

Tyrosinemias
Newborn Infant
Tyrosine
Inborn Genetic Diseases
Urine
Amino Acids
succinylacetone

Keywords

  • Newborn screening
  • Succynilacetone
  • Tyrosinemiatype I

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Newborn screening for tyrosinemia type I : Further evidence that succinylacetone determination on blood spot is essential. / La Marca, Giancarlo; Malvagia, Sabrina; Pasquini, Elisabetta; Cavicchi, Catia; Morrone, Amelia; Ciani, Federica; Funghini, Silvia; Villanelli, Fabio; Zammarchi, Enrico; Guerrini, Renzo.

In: Journal of Inherited Metabolic Disease, Vol. 1, 01.11.2011, p. 107-109.

Research output: Contribution to journalArticle

La Marca, G, Malvagia, S, Pasquini, E, Cavicchi, C, Morrone, A, Ciani, F, Funghini, S, Villanelli, F, Zammarchi, E & Guerrini, R 2011, 'Newborn screening for tyrosinemia type I: Further evidence that succinylacetone determination on blood spot is essential', Journal of Inherited Metabolic Disease, vol. 1, pp. 107-109. https://doi.org/10.1007/8904_2011_24
La Marca, Giancarlo ; Malvagia, Sabrina ; Pasquini, Elisabetta ; Cavicchi, Catia ; Morrone, Amelia ; Ciani, Federica ; Funghini, Silvia ; Villanelli, Fabio ; Zammarchi, Enrico ; Guerrini, Renzo. / Newborn screening for tyrosinemia type I : Further evidence that succinylacetone determination on blood spot is essential. In: Journal of Inherited Metabolic Disease. 2011 ; Vol. 1. pp. 107-109.
@article{6c174c04c2194605ad52d66fc579c859,
title = "Newborn screening for tyrosinemia type I: Further evidence that succinylacetone determination on blood spot is essential",
abstract = "Tyrosinemia type I is a genetic disorder characterized by accumulation in the blood and urine of the toxicmetabolite succinylacetone (SUAC), not detectable in healthy samples. In many countries, newborns are screened for tyrosinemia type I using tyrosine as a primary marker. Unfortunately, tyrosine accumulation may take longer to occur and it may be not obvious when specimens are collected, in the first few days of life, as for new born screening. In 2008, we reported changes to simultaneously measure acylcarnitines, amino acids, and SUAC duringexpanded newborn screening. We established the usefulness of this method after identifying a first asymptomatic new born affected by tyrosinemia type I. Now we report a second infant with positive SUAC screening result (14.1 mmol/L, n.v.",
keywords = "Newborn screening, Succynilacetone, Tyrosinemiatype I",
author = "{La Marca}, Giancarlo and Sabrina Malvagia and Elisabetta Pasquini and Catia Cavicchi and Amelia Morrone and Federica Ciani and Silvia Funghini and Fabio Villanelli and Enrico Zammarchi and Renzo Guerrini",
year = "2011",
month = "11",
day = "1",
doi = "10.1007/8904_2011_24",
language = "English",
volume = "1",
pages = "107--109",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Newborn screening for tyrosinemia type I

T2 - Further evidence that succinylacetone determination on blood spot is essential

AU - La Marca, Giancarlo

AU - Malvagia, Sabrina

AU - Pasquini, Elisabetta

AU - Cavicchi, Catia

AU - Morrone, Amelia

AU - Ciani, Federica

AU - Funghini, Silvia

AU - Villanelli, Fabio

AU - Zammarchi, Enrico

AU - Guerrini, Renzo

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Tyrosinemia type I is a genetic disorder characterized by accumulation in the blood and urine of the toxicmetabolite succinylacetone (SUAC), not detectable in healthy samples. In many countries, newborns are screened for tyrosinemia type I using tyrosine as a primary marker. Unfortunately, tyrosine accumulation may take longer to occur and it may be not obvious when specimens are collected, in the first few days of life, as for new born screening. In 2008, we reported changes to simultaneously measure acylcarnitines, amino acids, and SUAC duringexpanded newborn screening. We established the usefulness of this method after identifying a first asymptomatic new born affected by tyrosinemia type I. Now we report a second infant with positive SUAC screening result (14.1 mmol/L, n.v.

AB - Tyrosinemia type I is a genetic disorder characterized by accumulation in the blood and urine of the toxicmetabolite succinylacetone (SUAC), not detectable in healthy samples. In many countries, newborns are screened for tyrosinemia type I using tyrosine as a primary marker. Unfortunately, tyrosine accumulation may take longer to occur and it may be not obvious when specimens are collected, in the first few days of life, as for new born screening. In 2008, we reported changes to simultaneously measure acylcarnitines, amino acids, and SUAC duringexpanded newborn screening. We established the usefulness of this method after identifying a first asymptomatic new born affected by tyrosinemia type I. Now we report a second infant with positive SUAC screening result (14.1 mmol/L, n.v.

KW - Newborn screening

KW - Succynilacetone

KW - Tyrosinemiatype I

UR - http://www.scopus.com/inward/record.url?scp=84920916719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920916719&partnerID=8YFLogxK

U2 - 10.1007/8904_2011_24

DO - 10.1007/8904_2011_24

M3 - Article

AN - SCOPUS:84920916719

VL - 1

SP - 107

EP - 109

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

ER -